AVANT IMMUNOTHERAPEUTICS, INC. FORM 10-K

Company

Celldex Therapeutics, Inc.

Filed

March 25, 1999

Period of Report

December 31, 1998

Accession Number

0001029869-99-000359

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →